BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 895 filers reported holding BAXTER INTL INC in Q1 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $301,000 | -88.4% | 5,800 | -90.1% | 0.01% | -89.6% |
Q4 2016 | $2,603,000 | -19.3% | 58,700 | -13.4% | 0.05% | -28.4% |
Q3 2016 | $3,226,000 | -27.6% | 67,782 | -31.3% | 0.07% | -38.0% |
Q2 2016 | $4,458,000 | +5.9% | 98,606 | -3.8% | 0.11% | -21.2% |
Q1 2016 | $4,210,000 | +2.7% | 102,484 | -4.7% | 0.14% | +33.0% |
Q4 2015 | $4,100,000 | +10.6% | 107,484 | -4.8% | 0.10% | +1.0% |
Q3 2015 | $3,708,000 | -40.9% | 112,859 | +25.7% | 0.10% | -40.4% |
Q2 2015 | $6,278,000 | +651.0% | 89,770 | +635.8% | 0.17% | +850.0% |
Q1 2015 | $836,000 | -30.9% | 12,200 | -26.1% | 0.02% | -14.3% |
Q4 2014 | $1,209,000 | +58.9% | 16,500 | +55.6% | 0.02% | +50.0% |
Q3 2014 | $761,000 | +1.2% | 10,601 | +2.0% | 0.01% | +7.7% |
Q2 2014 | $752,000 | -58.4% | 10,392 | -60.0% | 0.01% | -48.0% |
Q4 2013 | $1,808,000 | – | 26,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |